Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Roquebert

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pathologie-Biologie|May 31, 2008
[HIV genetic diversity and its consequences]B Roquebert, F Damond, F Brun-Vézinet, et al.
Journal of Clinical Microbiology|August 24, 2007
Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assaysF Damond, B Roquebert, A Bénard, et al.
Medecine Et Maladies Infectieuses|February 7, 2018
Intensive care admission for Coronavirus OC43 respiratory tract infectionsD Vandroux, N Allou, J Jabot, et al.
The Journal of Antimicrobial Chemotherapy|August 23, 2008
HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitroB Roquebert, F Damond, G Collin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2009
High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trialY Yazdanpanah, C Fagard, D Descamps, et al.
Journal of Clinical Microbiology|February 5, 2010
Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantificationF Damond, V Avettand-Fenoel, G Collin, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pathologie-Biologie|May 31, 2008
[HIV genetic diversity and its consequences]B Roquebert, F Damond, F Brun-Vézinet, et al.
Journal of Clinical Microbiology|August 24, 2007
Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assaysF Damond, B Roquebert, A Bénard, et al.
Medecine Et Maladies Infectieuses|February 7, 2018
Intensive care admission for Coronavirus OC43 respiratory tract infectionsD Vandroux, N Allou, J Jabot, et al.
The Journal of Antimicrobial Chemotherapy|August 23, 2008
HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitroB Roquebert, F Damond, G Collin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2009
High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trialY Yazdanpanah, C Fagard, D Descamps, et al.
Journal of Clinical Microbiology|February 5, 2010
Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantificationF Damond, V Avettand-Fenoel, G Collin, et al.
Pageof 1